Search results
Jump to navigation
Jump to search
- ...(1200-mg IV bolus and 1200 mg orally twice daily for 2 days) benefited ([[relative risk reduction]] of 74%) patients receiving coronary angioplasty with higher volumes of co25 KB (3,375 words) - 22:06, 17 October 2016
- ...[[vancomycin]], for recurrence of C. difficile infection was 0.6 and the [[relative risk reduction]] was 40.0%. In populations similar to those in this study which had a rate ...[[vancomycin]], for recurrence of C. difficile infection was 0.6 and the [[relative risk reduction]] was 40.0%. In populations similar to those in this study which had a rate46 KB (6,252 words) - 17:10, 31 October 2013
- ...acotherapy]], as compared to [[placebo]], for mortality was 0.85 and the [[relative risk reduction]] was 15.0%. This finding did not reach [[statistical significance]]<ref na56 KB (7,418 words) - 15:13, 5 November 2013
- ...t [[tamoxifen]] can prevent breast cancer in high-risk individuals. The [[relative risk reduction]] was up to 50% of new breast cancers, though the cancers prevented were mo101 KB (14,716 words) - 09:04, 5 April 2024
- * [[Relative risk reduction]]55 KB (7,444 words) - 06:21, 29 August 2013
- * [[Relative risk reduction]]25 KB (3,600 words) - 14:27, 31 March 2024
- * [[Relative risk reduction]]63 KB (8,790 words) - 06:57, 2 March 2021
- Dichotomous outcomes may be summarized with [[relative risk reduction]], [[absolute risk reduction]], or the [[number needed to treat]].79 KB (10,925 words) - 14:12, 2 February 2023
- Dichotomous outcomes may be summarized with [[relative risk reduction]], [[absolute risk reduction]], or the [[number needed to treat]].87 KB (12,105 words) - 14:08, 2 February 2023